AT283600B - Verfahren zur Herstellung einer stabilen, wässerigen, injizierbaren Glucagonlösung - Google Patents

Verfahren zur Herstellung einer stabilen, wässerigen, injizierbaren Glucagonlösung

Info

Publication number
AT283600B
AT283600B AT26769A AT26769A AT283600B AT 283600 B AT283600 B AT 283600B AT 26769 A AT26769 A AT 26769A AT 26769 A AT26769 A AT 26769A AT 283600 B AT283600 B AT 283600B
Authority
AT
Austria
Prior art keywords
aqueous
stable
preparation
glucagon solution
injectable glucagon
Prior art date
Application number
AT26769A
Other languages
English (en)
Inventor
Jan Markussen
Original Assignee
Novo Terapeutisk Labor As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Novo Terapeutisk Labor As filed Critical Novo Terapeutisk Labor As
Application granted granted Critical
Publication of AT283600B publication Critical patent/AT283600B/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/22—Hormones
    • A61K38/26—Glucagons
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/16—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing nitrogen, e.g. nitro-, nitroso-, azo-compounds, nitriles, cyanates
    • A61K47/18—Amines; Amides; Ureas; Quaternary ammonium compounds; Amino acids; Oligopeptides having up to five amino acids
    • A61K47/186—Quaternary ammonium compounds, e.g. benzalkonium chloride or cetrimide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Endocrinology (AREA)
  • Immunology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
AT26769A 1968-01-10 1969-01-10 Verfahren zur Herstellung einer stabilen, wässerigen, injizierbaren Glucagonlösung AT283600B (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB0536/68A GB1202607A (en) 1968-01-10 1968-01-10 Improvements in or relating to stable glucagon solutions and their preparation

Publications (1)

Publication Number Publication Date
AT283600B true AT283600B (de) 1970-08-10

Family

ID=9723689

Family Applications (1)

Application Number Title Priority Date Filing Date
AT26769A AT283600B (de) 1968-01-10 1969-01-10 Verfahren zur Herstellung einer stabilen, wässerigen, injizierbaren Glucagonlösung

Country Status (7)

Country Link
AT (1) AT283600B (de)
BE (1) BE726681A (de)
DE (1) DE1900367A1 (de)
FR (1) FR2000114A1 (de)
GB (1) GB1202607A (de)
IT (1) IT974528B (de)
NL (1) NL6900460A (de)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5482931A (en) * 1993-06-29 1996-01-09 Ferring Ab Stabilized pharmaceutical peptide compositions
US7235627B2 (en) 1996-08-30 2007-06-26 Novo Nordisk A/S Derivatives of GLP-1 analogs
US6458924B2 (en) 1996-08-30 2002-10-01 Novo Nordisk A/S Derivatives of GLP-1 analogs
ATE269103T1 (de) * 1998-03-13 2004-07-15 Novo Nordisk As Stabilisierte wässerige glukagonlösungen enthaltend detergenzien
WO1999047160A1 (en) * 1998-03-13 1999-09-23 Novo Nordisk A/S Stabilized aqueous peptide solutions
WO2011049713A2 (en) 2009-10-22 2011-04-28 Biodel Inc. Stabilized glucagon solutions
US9610329B2 (en) 2009-10-22 2017-04-04 Albireo Pharma, Inc. Stabilized glucagon solutions
ES2533601T3 (es) 2010-11-03 2015-04-13 Arecor Limited Nueva composición que comprende glucagón
CN113730555A (zh) 2012-01-09 2021-12-03 阿道恰公司 Ph为7且至少含pi为5.8至8.5之基础胰岛素和取代共聚(氨基酸)的可注射溶液
US20150314003A2 (en) 2012-08-09 2015-11-05 Adocia Injectable solution at ph 7 comprising at least one basal insulin the isoelectric point of which is between 5.8 and 8.5 and a hydrophobized anionic polymer
EP3463294B1 (de) * 2016-06-07 2020-08-05 Adocia Zusammensetzungen in form einer injizierbaren wässrigen lösung mit menschlichem glucagon und einer statistischen copolyaminosäure
FR3061660B1 (fr) * 2017-01-10 2019-05-31 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3052071B1 (fr) * 2016-06-07 2018-09-07 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon et un co-polyaminoacide
GB201611077D0 (en) 2016-06-24 2016-08-10 Arecor Ltd Novel composition
WO2019110838A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3074683B1 (fr) * 2017-12-07 2020-01-10 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
FR3083087A1 (fr) 2018-06-29 2020-01-03 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
MA51018A (fr) 2017-12-07 2020-10-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
WO2019110836A1 (fr) 2017-12-07 2019-06-13 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide
JP2021505597A (ja) 2017-12-07 2021-02-18 アドシア ヒトグルカゴンおよびコポリアミノ酸を含む注射水溶液の形態の組成物
FR3067247A1 (fr) 2018-06-07 2018-12-14 Adocia Compositions sous forme d'une solution aqueuse injectable comprenant du glucagon humain et un co-polyaminoacide

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2643967A (en) * 1946-08-31 1953-06-30 Wallerstein Co Inc Concentrate of tyrothricin and its therapeutically active components
NL94376C (nl) * 1958-04-28 1960-05-16 Nv Organon Werkwijze ter bereiding van injicieerbare glacagonpreparaten met verlengde werking

Also Published As

Publication number Publication date
NL6900460A (de) 1969-07-14
IT974528B (it) 1974-07-10
DE1900367A1 (de) 1969-09-04
GB1202607A (en) 1970-08-19
BE726681A (de) 1969-07-09
FR2000114A1 (fr) 1969-08-29

Similar Documents

Publication Publication Date Title
AT283600B (de) Verfahren zur Herstellung einer stabilen, wässerigen, injizierbaren Glucagonlösung
AT291441B (de) Verfahren zur Herstellung von wässerigen Lösungen von α-6-Desoxy-5-hydroxytetracyclin
CH520753A (de) Verfahren zur Herstellung von Azoverbindungen
AT305229B (de) Verfahren zur Herstellung von S-1,2-Dihydroxy-3-aminopropan
CH530207A (de) Verfahren zur Herstellung von Na(A1),Ne(B29)-Di-tert.-Butyloxycarbonyl-insulin
CH556335A (de) Verfahren zur herstellung von substituierten phenoxypyrrolidinen.
CH499597A (de) Verfahren zur Herstellung von Azoverbindungen
CH537922A (de) Verfahren zur Herstellung von 2-Alkyl-4,5-diphenylpyrrolderivaten
AT287707B (de) Verfahren zur Herstellung von Isothiazolderivaten
CH522660A (de) Verfahren zur Herstellung von Imidazoliumsalzen
AT354634B (de) Verfahren zur herstellung injizierbarer insulinpraeparate
CH508616A (de) Verfahren zur Herstellung von 2-Alkyl-3-hydroxy-4,5-dihydrofuran-4-onen
CH515993A (de) Verfahren zur Herstellung einer Dextrinlösung
CH447204A (de) Verfahren zur Herstellung einer Trioxanlösung
AT305303B (de) Verfahren zur kontinuierlichen Herstellung einer wässerigen Harnstofflösung
CH529150A (de) Verfahren zur Herstellung von 1-Azacyclo-4-imino-1,4-dihydropyridinen
CH516599A (de) Verfahren zur Herstellung von O,O-Dialkylthiono-phosphorsäurechloriden
CH510086A (de) Verfahren zur Herstellung von Azoverbindungen
CH544731A (de) Verfahren zur Herstellung von unsymmetrischen, substituierten Diphenyläthenen mit pharmakologischer Aktivität
CH518972A (de) Verfahren zur Herstellung einer Chromenopyrazolverbindung
AT286497B (de) Verfahren zur Herstellung einer Vaccine
AT249872B (de) Verfahren zur Herstellung von wässerigen, protaminaktiven, injizierbaren Lösungen mit verbesserter Stabilität
CH478075A (de) Verfahren zur Herstellung von wässrigen Alkylphenolpolyglykoläther- Lösungen verminderter Viskosität
CH468347A (de) Verfahren zur Herstellung von a,w-Diaminoalkancarbonsäuren
AT311385B (de) Verfahren zur Herstellung einer Katalysatorzusammensetzung

Legal Events

Date Code Title Description
ELJ Ceased due to non-payment of the annual fee